Posted on July 18, 2014
Based on a study that included more than 1 million women, DCEG investigators and colleagues have determined that a negative test for human papillomavirus (HPV) infection compared to a negative Pap test provides greater safety, or assurance, against future risk of cervical cancer. That is, women who test negative on the HPV test have an extremely low risk of developing cervical cancer. The findings appeared online July 18, 2014, in the Journal of the National Cancer Institute. Read the full NCI press release on this study
Reference: Gage JC, Schiffman M, Katki HA, et al. Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. J Natl Cancer Inst 2014; 106(8).doi: 10.1093/jnci/dju153.